Skip to main content

Table 1 Patient characteristics of patients with Wilson Disease

From: The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study

Patient characteristics

WD (n = 76)

Controls (n = 76)

p

WD- neuro− (n = 43)

WD-neuro+ (n = 33)

p

Age (years)

37 (27–49)

36 (27–51)

0.98

37 (26–49)

35 (27.5–50)

0.82

Female (n)

36 (47%)

36 (47%)

1.00

24 (56%)

12 (36%)

0.09

BSA (m2)

1.93 ± 0.25

1.92 ± 0.22

0.34

1.90 ± 0.24

1.96 ± 0.26

0.30

BMI (kg/m2)

24 ± 4

24 ± 3

0.20

24 ± 3

25 ± 4

0.48

Heart rate (bpm)

70 ± 13

68 ± 11

0.46

72 ± 13

66 ± 13

0.06

Systolic blood pressure (mmHg)

120 ± 12

122 ± 12

0.43

121 ± 13

119 ± 10

0.65

Diastolic blood pressure (mmHg)

72 ± 13

69 ± 6

0.24

71 ± 14

75 ± 11

0.28

Hypertension

11%

14%

0.61

5%

18%

0.07

Hypercholesterolemia

11%

9%

0.67

10%

13%

0.71

Diabetes mellitus

3%

0%

0.27

2%

3%

0.85

History of smoking

23%

19%

0.62

19%

31%

0.21

Family history of CAD

12%

26%

0.05

12%

13%

0.91

Atrial fibrillation

5%

0%

 < 0.05

7%

3%

0.45

Heart failure

2.6%

0%

0.31

0%

6%

0.10

  1. Patient Characteristics of Wilson Disease (WD) patients compared to Controls and WD patients without (WD-neuro−) and with neurological symptoms (WD-neuro+): BSA, body surface area; BMI, body mass index; bpm, beats per minute; CAD, coronary artery disease. Values are mean ± SD, median (interquartile range) or n (%). Differences between groups were calculated using t-test, Mann–Whitney U test or chi-squared test